EquityZen Review 2026: Now a Morgan Stanley Subsidiary

EquityZen is no longer an independent startup. Morgan Stanley Wealth Management completed its acquisition of the platform in January 2026 and cut transaction fees from 5% to 2.5% for both buyers and sellers within weeks of closing. If you are an accredited investor looking to buy shares in late-stage private companies before they go public, EquityZen is still very much operating, still the price leader among major pre-IPO platforms, and still using the same special purpose vehicle structure it has used since 2015. But the acquisition reshapes the context in ways every prospective investor should understand before committing capital.

What the Morgan Stanley Acquisition Actually Changes

EquityZen was founded in 2013 and spent a decade building a retail-accessible pre-IPO marketplace. Morgan Stanley's acquisition, announced in 2025 and closed in January 2026, turns it into a subsidiary of the world's largest wealth manager. Atish Davda, EquityZen's founder, joined Morgan Stanley in the transaction and continues to run EquityZen within the bank's wealth management unit.

The fee cut is real and significant. A February 2026 Morgan Stanley press release confirmed that buy-side and sell-side fees both dropped to 2.5% immediately. That means the all-in cost of a buy-and-sell round trip fell from 10% to 5% of invested capital in fees. If you were watching EquityZen before the acquisition and balked at the fee structure, that objection has substantially less force now.

The competitive picture shifted at the same time. Bloomberg reported that Charles Schwab struck a deal to acquire Forge Global Holdings around the same period, and Goldman Sachs agreed to buy Industry Ventures. Three of the largest pre-IPO marketplace operators changed parent hands within months of each other. Forge still lists 5% fees, according to its website at time of writing. EquityZen is now the low-cost option among the major players, and Morgan Stanley's Jed Finn said the bank would "go as low as we need to go to make sure clients get the best possible price in the marketplace."

What does not change: the SPV structure, the accredited-investor requirement, the illiquidity profile, and the fundamental risks of buying a minority interest in a private company at a negotiated price. Morgan Stanley's backing provides institutional credibility and scale. It does not eliminate the underlying investment risks.

How EquityZen Actually Works

A transaction starts with a seller: an employee with vested stock options, an angel investor, or an early institutional backer who wants to monetize shares before the company reaches a public market. The seller contacts EquityZen and lists shares. EquityZen then surfaces the opportunity to registered accredited investors on the platform.

The mechanics of the transfer matter. Most private company shareholder agreements restrict direct share transfers. A company can block a sale outright or exercise a right of first refusal to buy the shares at the offered price before any outside buyer can purchase them. EquityZen's model requires company approval for each transaction. The company reviews the deal, waives its right of first refusal if it chooses, and permits the transfer. EquityZen markets this as "company-approved" transactions and Morgan Stanley intends to preserve the model, positioning it as a source of legitimacy versus platforms that match buyers and sellers without issuer involvement.

Once the company approves, EquityZen creates a new Delaware LLC, known as a special purpose vehicle (SPV). The SPV acquires the shares from the seller. You, as the buyer, purchase a membership interest in the SPV rather than the shares themselves. As EquityZen's own educational materials explain, the SPV acts as a "temporary holding company designed for a particular transaction or investment." The structure exists because it allows EquityZen to pool investors and because the actual share transfer happens at the SPV level, keeping the company's cap table clean from the issuer's perspective.

The SPV Structure in the SEC Record

Each SPV files a Form D with the SEC under Regulation D. EquityZen's retail product, Growth Technology Fund LLC, has filed hundreds of individual series since 2016, with each series corresponding to one underlying company position. The entity EquityZen Securities LLC acts as the broker-dealer across these offerings. A January 2024 Form D for Series 1781 of that fund (CIK 0002000567, accession 0002000567-24-000001) shows a $10,000 minimum investment for that specific series and 14 investors. Each series claims the Rule 506(b) exemption with an Investment Company Act Section 3(c)(1) exclusion, the standard structure for private placement funds with fewer than 100 beneficial owners.

EquityZen also operates Growth Technology Fund II, an institutional channel with significantly larger per-ticket sizes. A third-party analysis by AltStreet Research of EDGAR records found that Growth Technology Fund II's cumulative average subscription runs around $123,858, compared to roughly $29,088 for the retail Growth Technology Fund. A June 2026 Form D/A for EquityZen Growth Opportunity Fund XI LLC, Series 1 (CIK 0002085513, filed June 5, 2026), confirms the platform continues to register new vehicles with the SEC post-acquisition.

In July 2026, EquityZen registered a sixth fund family, Growth Access Fund LLC, under a Section 3(c)(7) structure, which applies to funds sold exclusively to qualified purchasers (generally individuals with $5 million or more in investments). This represents a stratification of the product shelf: a $5,000-minimum retail channel, a six-figure institutional channel, and a new qualified-purchaser tier. According to AltStreet Research's August 2026 census, EquityZen's total SEC-filed record now stands at 1,933 funded special purpose vehicles and $1,565,205,422 raised across 49,673 subscription positions since 2015. That is an active, growing platform, not a platform in decline.

Fees, Minimums, and the Express Deals Feature

The current fee structure is 2.5% charged to the buyer and 2.5% charged to the seller on most transactions. The $5,000 published minimum is the retail floor. Individual SPVs may require higher minimums depending on the deal size and how many investors a given series accepts. The Series 1781 Form D example above shows a $10,000 minimum for that specific vehicle. Confirm the minimum for any specific deal you find on the platform before planning your investment size.

Express Deals are worth understanding because they are the only active secondary path available to existing EquityZen investors. If you hold a membership interest in an EquityZen fund and want to exit before the underlying company has a liquidity event, you can list your interest for sale to another investor on the platform. The pricing depends on finding a willing buyer at a price you both agree on. There is no market-clearing mechanism setting a fair price, and not every fund series qualifies for Express Deals. Morgan Stanley's acquisition explicitly extended the fee reduction to Express Deals: transactions where an investor sells a fund interest to another investor on the platform now also carry the 2.5% rate rather than the previous 5%.

One structural note: the SPV fees disclosed in the Form D (amounts raised, investor counts) do not tell the full story of what a deal costs. EquityZen's offering documents for individual SPVs may include additional management or administrative fees at the fund level. Review the offering materials for any specific deal, not just the headline transaction fee, before committing.

What Companies Appear and Why EquityZen Does Not Name Them in SEC Filings

EquityZen's Form D filings since 2016 do not disclose which company each SPV holds. This anonymity practice is deliberate: naming the portfolio company in a public filing could trigger securities law complications around material nonpublic information or create conflicts with the company's own disclosure preferences. On the platform itself, deal listings are visible to registered accredited investors after identity verification.

EquityZen's marketing materials reference completed placements across approximately 500 private companies in its 11-year history. The company-approval model means only companies that actively choose to permit secondary sales appear on the platform. Historically, the platform has provided access to well-known late-stage companies across enterprise software, consumer technology, fintech, and biotechnology sectors. Morgan Stanley's addition of its own corporate relationships and cap table management capabilities through its Workplace channel should expand the available deal flow over time.

Exit Paths and Honest Risk Assessment

Your exit options as an EquityZen investor are: the underlying company IPOs, the company gets acquired, or you sell your fund interest through an Express Deal. Each path carries real constraints you should model before investing.

An IPO can be delayed for years or cancelled entirely. The IPO window opens and closes with public market conditions, and a company that was widely expected to go public in 2023 may still be private in 2028. An acquisition might happen at a valuation below what you paid. The private market valuation at which you bought your SPV interest may have reflected peak enthusiasm for a sector or company that later fell out of favor.

This could go wrong in compounding ways. The SPV structure places an additional entity between you and the underlying asset. That entity has its own fees and administrative costs. The purchase price you pay is negotiated between the seller, EquityZen, and whatever market demand exists on the platform at that moment, not discovered through transparent bidding or public market trading. You are exposed to valuation risk from the moment you buy. Morgan Stanley's own disclosure language, published alongside the acquisition announcement, states that accredited investors using the platform should be "willing to forgo liquidity and put capital at risk for an indefinite period of time" and acknowledges that investors "could lose all or a substantial amount of their investment."

The Form D itself provides limited investor protection. It discloses amounts raised and exemptions claimed, not the underlying holding, the deal terms, or the financial condition of the private company. EquityZen provides offering documents for each SPV through the platform, but unlike public company filings, those materials are not audited under the same standards and do not carry the same disclosure obligations as a registered securities offering.

EquityZen vs. the Competition

Forge Global is EquityZen's most direct comparable. Forge operates a similar secondary marketplace for pre-IPO shares and is currently pending acquisition by Charles Schwab. Forge's listed fee is 5% on both sides, making EquityZen currently cheaper by a full percentage point on each side of a trade. Both platforms operate in the same accredited-investor space and both use SPV or fund structures to handle private share transfers.

Hiive operates in the same general category but focuses more heavily on larger institutional ticket sizes and positions itself as a broker-operated marketplace rather than a technology-first retail platform. EquityBee occupies a different niche entirely, helping startup employees exercise stock options rather than facilitating secondary sales of already-vested shares. The two platforms address different problems for different types of sellers. Neither Forge, Hiive, nor EquityBee matches EquityZen's current 2.5% fee structure for accredited retail investors.

My view: if you are a retail accredited investor with $5,000 to $50,000 to allocate to a single pre-IPO position, EquityZen is the most accessible entry point among the major platforms on fee structure and minimum investment. The Morgan Stanley parent adds operational stability and scale. That does not change the fundamental illiquidity and valuation risks of the asset class itself.

For more on this, see our related coverage:

• Carta Review 2026: What Happened After Carta Killed Its Own Secondary Market
• 8-Step Checklist to Vet a Pre-IPO SPV Sponsor Before Committing Capital
• Pre-IPO 'Access' Is Not the Product. Price Discipline Is.

Frequently Asked Questions

Who qualifies to invest on EquityZen?

You must meet the SEC's definition of accredited investor: individual income above $200,000 per year ($300,000 combined with a spouse or spousal equivalent) in each of the two most recent years, or net worth exceeding $1 million excluding your primary residence. Holders of certain financial licenses (Series 7, 65, or 82) also qualify. EquityZen's institutional fund families require qualified purchaser status, generally $5 million or more in investments.

How do I access liquidity before the company goes public?

Your primary option before a company IPO or acquisition is EquityZen's Express Deals, which lets you list your fund interest for sale to another investor on the platform. There is no guarantee of finding a buyer at your desired price, no set market price mechanism, and not every fund series participates in Express Deals. Treat any EquityZen investment as illiquid until a corporate liquidity event occurs.

What happens if the company I invested in never IPOs or gets acquired?

You could lose your entire investment. The SPV holds shares of one specific private company. If that company fails, is dissolved, or remains private indefinitely with no viable exit, your membership interest in the SPV has no realizable value. EquityZen's parent company's own disclosure language explicitly states that investors could lose all or a substantial amount of their investment in these vehicles.

Does EquityZen independently verify the company's valuation?

No. EquityZen requires company approval for each transaction, which establishes that the transfer is permitted, not that the price is fair. The price reflects what a willing seller accepts and what the platform's investor demand will support at that moment. You are responsible for your own analysis of whether the offered valuation is reasonable relative to the company's financial condition, growth trajectory, and comparable public-market benchmarks.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.